Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Phreesia Inc (NY: PHR )

26.00 +0.59 (+2.32%)
Streaming Delayed Price Updated: 10:08 AM EDT, Aug 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Phreesia Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Bob Glazer Joins Phreesia as Strategic Advisor
From Phreesia
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results
From Phreesia, Inc.
Via Business Wire
A Glimpse Into The Expert Outlook On Phreesia Through 6 Analysts
Via Benzinga
Assessing Phreesia: Insights From 12 Financial Analysts
Via Benzinga
Analyst Expectations For Phreesia's Future
Via Benzinga
Phreesia Now Available on Oracle Healthcare Marketplace
From Phreesia
Via Business Wire
Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
PHREESIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Phreesia, Inc. on Behalf of Phreesia Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Recap: Phreesia Q4 Earnings
Via Benzinga
Phreesia Earnings Preview
Via Benzinga
Assessing Phreesia: Insights From 7 Financial Analysts
Via Benzinga
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Phreesia, Inc. (PHR)
From Kirby McInerney LLP
Via Business Wire
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease
From Phreesia
Via Business Wire
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
PHR Stock Earnings: Phreesia Beats EPS, Beats Revenue for Q1 2025
PHR stock results show that Phreesia beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. 
Via InvestorPlace
Phreesia Announces First Quarter Fiscal 2025 Results
From Phreesia, Inc.
Via Business Wire
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner
From Phreesia
Via Business Wire
Phreesia’s Amy Patel Named One of PM360’s 2024 ELITE 100
From Phreesia
Via Business Wire
Phreesia Named as One of Modern Healthcare’s “Best Places to Work in Healthcare” for the Eighth Time
From Phreesia
Via Business Wire
Phreesia’s Alicia Cowley and Natasha Vega Named to MM+M’s ‘Women to Watch’ for 2024
From Phreesia
Via Business Wire
Phreesia Sets Release Date for Fiscal First Quarter 2025 Results
From Phreesia, Inc.
Via Business Wire
Phreesia Announces Jack Callahan as New Chief Technology Officer
From Phreesia
Via Business Wire
PHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024
PHR stock results show that Phreesia missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Phreesia Announces Fourth Quarter Fiscal 2024 Results
From Phreesia, Inc.
Via Business Wire
Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
From Phreesia
Via Business Wire
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.